Annual Accounts Payable
$155.80 M
+$125.67 M+417.18%
December 31, 2022
Summary
- As of February 7, 2025, HZNP annual accounts payable is $155.80 million, with the most recent change of +$125.67 million (+417.18%) on December 31, 2022.
- During the last 3 years, HZNP annual accounts payable has risen by +$134.29 million (+624.18%).
Performance
HZNP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$85.54 M
+$8.92 M+11.65%
June 30, 2023
Summary
- As of February 7, 2025, HZNP quarterly accounts payable is $85.54 million, with the most recent change of +$8.92 million (+11.65%) on June 30, 2023.
- Over the past year, HZNP quarterly accounts payable has increased by +$67.00 million (+361.45%).
Performance
HZNP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
HZNP Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +417.2% | +361.4% |
3 y3 years | +624.2% | -19.3% |
5 y5 years | +349.2% | +175.0% |
HZNP Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -80.7% | -45.1% | -78.3% |
5 y | 5-year | at high | -86.2% | -45.1% | -78.3% |
alltime | all time | at high | -99.0% | -45.1% | -97.9% |
Horizon Therapeutics Public Limited Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $85.54 M(+11.6%) |
Mar 2023 | - | $76.62 M(-50.8%) |
Dec 2022 | $155.80 M(+417.2%) | $155.80 M(+385.2%) |
Sep 2022 | - | $32.11 M(+73.2%) |
Jun 2022 | - | $18.54 M(-72.3%) |
Mar 2022 | - | $67.01 M(+122.5%) |
Dec 2021 | $30.13 M(-20.1%) | $30.13 M(-40.6%) |
Sep 2021 | - | $50.72 M(-2.4%) |
Jun 2021 | - | $51.95 M(+20.8%) |
Mar 2021 | - | $42.99 M(+14.0%) |
Dec 2020 | $37.71 M(+75.3%) | $37.71 M(-3.3%) |
Sep 2020 | - | $38.98 M(-63.2%) |
Jun 2020 | - | $106.02 M(+111.5%) |
Mar 2020 | - | $50.12 M(+133.0%) |
Dec 2019 | $21.51 M(-29.0%) | $21.51 M(-20.0%) |
Sep 2019 | - | $26.91 M(-36.9%) |
Jun 2019 | - | $42.67 M(+17.0%) |
Mar 2019 | - | $36.46 M(+20.4%) |
Dec 2018 | $30.28 M(-12.7%) | $30.28 M(-53.3%) |
Sep 2018 | - | $64.79 M(+108.3%) |
Jun 2018 | - | $31.11 M(-24.6%) |
Mar 2018 | - | $41.27 M(+19.0%) |
Dec 2017 | $34.68 M(-33.9%) | $34.68 M(+5.7%) |
Sep 2017 | - | $32.83 M(-59.9%) |
Jun 2017 | - | $81.88 M(-6.7%) |
Mar 2017 | - | $87.74 M(+67.2%) |
Dec 2016 | $52.48 M | $52.48 M(-20.1%) |
Sep 2016 | - | $65.68 M(+11.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2016 | - | $58.97 M(-15.4%) |
Mar 2016 | - | $69.67 M(+320.0%) |
Dec 2015 | $16.59 M(-21.0%) | $16.59 M(-73.3%) |
Sep 2015 | - | $62.08 M(+136.7%) |
Jun 2015 | - | $26.22 M(+19.4%) |
Mar 2015 | - | $21.96 M(+4.5%) |
Dec 2014 | $21.01 M(+111.8%) | $21.01 M(-5.3%) |
Sep 2014 | - | $22.20 M(+39.6%) |
Jun 2014 | - | $15.90 M(+54.8%) |
Mar 2014 | - | $10.27 M(+3.5%) |
Dec 2013 | $9.92 M(+65.7%) | $9.92 M(+96.7%) |
Sep 2013 | - | $5.04 M(-10.3%) |
Jun 2013 | - | $5.62 M(+13.8%) |
Mar 2013 | - | $4.94 M(-17.4%) |
Dec 2012 | $5.99 M(-26.7%) | $5.99 M(-12.7%) |
Sep 2012 | - | $6.85 M(-13.1%) |
Jun 2012 | - | $7.89 M(-9.8%) |
Mar 2012 | - | $8.75 M(+7.1%) |
Dec 2011 | $8.17 M(+225.0%) | $8.17 M(+119.4%) |
Sep 2011 | - | $3.72 M(-26.2%) |
Jun 2011 | - | $5.04 M(+30.5%) |
Mar 2011 | - | $3.87 M(+53.7%) |
Dec 2010 | $2.51 M(+42.8%) | $2.51 M(-42.9%) |
Sep 2010 | - | $4.40 M(+14.5%) |
Jun 2010 | - | $3.85 M(+70.3%) |
Mar 2010 | - | $2.26 M(+28.3%) |
Dec 2009 | $1.76 M(+8.4%) | $1.76 M |
Dec 2008 | $1.62 M | - |
FAQ
- What is Horizon Therapeutics Public Limited annual accounts payable?
- What is the all time high annual accounts payable for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual accounts payable year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly accounts payable year-on-year change?
What is Horizon Therapeutics Public Limited annual accounts payable?
The current annual accounts payable of HZNP is $155.80 M
What is the all time high annual accounts payable for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual accounts payable is $155.80 M
What is Horizon Therapeutics Public Limited annual accounts payable year-on-year change?
Over the past year, HZNP annual accounts payable has changed by +$125.67 M (+417.18%)
What is Horizon Therapeutics Public Limited quarterly accounts payable?
The current quarterly accounts payable of HZNP is $85.54 M
What is the all time high quarterly accounts payable for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly accounts payable is $155.80 M
What is Horizon Therapeutics Public Limited quarterly accounts payable year-on-year change?
Over the past year, HZNP quarterly accounts payable has changed by +$67.00 M (+361.45%)